APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.42
+3.97%5
Insider buys (3m)
0
Insider sells (3m)
$8.3M
Net value (3m)
-2.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 17, 2026 | LIN PETER KUAN-HOW · director, officer: Chief Financial Officer | M-Exempt | 10,000 | $0.00 |
| Sep 17, 2026 | Chen Hung-Wen · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 8,000 | $23 |
| Sep 17, 2026 | Chen Hung-Wen · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 5,000 | $0.00 |
| Sep 17, 2026 | Huang Ya-Chi · director | A-Award | 2,000 | $23 |
| Sep 17, 2026 | Yen Hung Hsien · director | A-Award | 2,000 | $23 |
| Sep 17, 2026 | Yen Hung Hsien · director | M-Exempt | 500 | $0.00 |
| Sep 17, 2026 | TSAI HSIEN-SHU · director | A-Award | 2,000 | $23 |
| Sep 17, 2026 | TSAI HSIEN-SHU · director | M-Exempt | 500 | $0.00 |
| Sep 17, 2026 | Chen Yi-Kuei · director, officer: Chief Operating Officer | A-Award | 8,000 | $23 |
| Sep 17, 2026 | Chen Yi-Kuei · director, officer: Chief Operating Officer | M-Exempt | 5,000 | $0.00 |
| Sep 17, 2026 | CHEN HONG-JUNG · director | A-Award | 2,000 | $23 |
| Sep 17, 2026 | CHEN HONG-JUNG · director | M-Exempt | 500 | $0.00 |
| Sep 17, 2026 | LIN PETER KUAN-HOW · director, officer: Chief Financial Officer | A-Award | 6,000 | $23 |
| Sep 17, 2026 | LIN PETER KUAN-HOW · director, officer: Chief Financial Officer | F-InKind | 3,416 | $24 |
| Aug 24, 2026 | Huang Ya-Chi · director | M-Exempt | 500 | $0.00 |
| Aug 17, 2026 | Chen Hung-Wen · director, officer: Chief Executive Officer | Purchase | 166,667 | $12 |
| Aug 17, 2026 | Chen Hung-Wen · director, officer: Chief Executive Officer | Purchase | 266,667 | $15 |
| Aug 17, 2026 | Chen Hung-Wen · director, officer: Chief Executive Officer | Purchase | 103,333 | $15 |
| Aug 17, 2026 | LIN PETER KUAN-HOW · officer: Chief Financial Officer | Purchase | 26,667 | $15 |
| Aug 17, 2026 | Chen Yi-Kuei · director, officer: Chief Operating Officer | Purchase | 20,000 | $15 |
| Jun 17, 2026 | LIN PETER KUAN-HOW · director, officer: Chief Financial Officer | M-Exempt | 10,000 | $0.00 |
| Jun 17, 2026 | LIN PETER KUAN-HOW · director, officer: Chief Financial Officer | F-InKind | 3,588 | $14 |
| Jun 16, 2026 | CHU YI-AN · director | M-Exempt | 500 | $0.00 |
| Jun 16, 2026 | Jan Chen-Huan · director | M-Exempt | 500 | $0.00 |
| Jun 16, 2026 | Chen Yi-Kuei · director, officer: Chief Operating Officer | M-Exempt | 5,000 | $0.00 |
| Jun 16, 2026 | TSAI HSIEN-SHU · director | M-Exempt | 500 | $0.00 |
| Jun 16, 2026 | CHEN HONG-JUNG · director | M-Exempt | 500 | $0.00 |
| Jun 16, 2026 | Chen Hung-Wen · director, officer: Chief Executive Officer | M-Exempt | 5,000 | $0.00 |
| May 19, 2026 | Huang Ya-Chi · director | M-Exempt | 500 | $0.00 |
| Apr 17, 2026 | LIN PETER KUAN-HOW · officer: Chief Financial Officer | F-InKind | 3,582 | $16 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 1Reduced 1Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 10,664 | Sep 2, 2026 |
| CITIGROUP INC | New Position | 438 | May 11, 2026 |
| UBS GROUP AG | Increased | 142 | May 5, 2026 |
| SBI Securities Co., Ltd. | Unchanged | 9 | Jul 23, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 9 | Apr 28, 2026 |
| UBS Group AG | Reduced | 2 | Aug 13, 2026 |
| BlackRock, Inc. | Unchanged | 1 | Aug 7, 2026 |
| BLACKROCK, INC. | Unchanged | 1 | May 13, 2026 |
| CITIGROUP INC | Sold Out | 0 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 17, 2026